Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.95
+0.09 (1.45%)
Feb 5, 2025, 10:50 AM EST - Market open
Abeona Therapeutics Employees
Abeona Therapeutics had 84 employees as of December 31, 2023. The number of employees increased by 27 or 47.37% compared to the previous year.
Employees
84
Change (1Y)
27
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$845,619
Market Cap
258.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABEO News
- 2 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued - Seeking Alpha
- 2 months ago - Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Participation in November Investor Conferences - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration - GlobeNewsWire
- 4 months ago - Abeona Therapeutics Targets RDEB Market With Promising Pz-cel Therapy - Seeking Alpha
- 5 months ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire